Company Filing History:
Years Active: 2005-2006
Title: **Michael Robert Dunlavey: Innovator in Pharmaceutical Computing**
Introduction
Michael Robert Dunlavey, an accomplished inventor based in Needham, MA, is recognized for his innovative contributions to pharmaceutical computing, particularly in drug model generation and clinical trial simulation. With a portfolio of three patents, Dunlavey has made significant strides in enhancing the processes involved in pharmacological modeling and clinical trial protocols.
Latest Patents
Dunlavey's latest work includes two notable patents that showcase his expertise in creating interactive and efficient systems for drug modeling and clinical trials. The first patent, titled "Interactive Graphical Environment for Drug Model Generation," presents a method of interactively constructing pharmacological computational models. This innovation features a graphical user interface that allows users to place and connect objects representing pharmacokinetic and pharmacodynamic elements. As models are constructed, they are converted into an internal format, allowing users to verify their models in real time. A summarized form presents key equations or graphs of variable behaviors, facilitating immediate understanding.
The second patent, "System and Method for Simulating Clinical Trial Protocols with Compiled State Machines," focuses on optimizing clinical trials. This system receives input data that represents a clinical trial protocol and organizes it into various schedules, including dosage and observation schedules. These schedules are translated into a high-level programming language, compiled into an executable file, and run by a trial simulator to accurately simulate the clinical trial protocol.
Career Highlights
Throughout his career, Michael Robert Dunlavey has been affiliated with Pharsight Corporation, where he has leveraged his skills to develop pioneering technologies in the pharmaceutical sector. His contributions have been vital for researchers and companies aiming to streamline drug testing and clinical trial processes.
Collaborations
Dunlavey has collaborated with talented professionals such as David J Hermann and Jeffrey Alan Wald. Together, they have worked on projects that push the boundaries of pharmaceutical innovation, making a significant impact in the industry.
Conclusion
Michael Robert Dunlavey stands out as a key figure in the realm of pharmaceutical computing. His innovative patents and ongoing contributions to drug model generation and clinical trial simulation illustrate his commitment to advancing the field. With a focus on creating interactive and efficient systems, Dunlavey's work continues to influence the landscape of pharmaceutical research and development.